11:51 AM
Mar 08, 2018
 |  BC Extra  |  Financial News

Cyteir raises $29M series B

Cyteir Therapeutics Inc. (Cambridge, Mass.) raised $29 million in a series B round led by Venrock. Existing investor Celgene Corp. (NASDAQ:CELG) participated alongside new investors Lightstone Ventures and DROIA...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >